ChitogenX Valuation

CHNXF Stock  USD 0.01  0.0001  2.00%   
ChitogenX seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of ChitogenX from analyzing the firm fundamentals such as Shares Outstanding of 51.04 M, ebitda of (3.72 M), and Return On Asset of -2.92 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
0.01
Please note that ChitogenX's price fluctuation is out of control at this time. Calculation of the real value of ChitogenX is based on 3 months time horizon. Increasing ChitogenX's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ChitogenX otc stock is determined by what a typical buyer is willing to pay for full or partial control of ChitogenX. Since ChitogenX is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ChitogenX OTC Stock. However, ChitogenX's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0051 Real  0.004896 Hype  0.006968 Naive  0.003434
The real value of ChitogenX OTC Stock, also known as its intrinsic value, is the underlying worth of ChitogenX OTC Stock, which is reflected in its stock price. It is based on ChitogenX's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ChitogenX's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0
Real Value
7.93
Upside
Estimating the potential upside or downside of ChitogenX helps investors to forecast how ChitogenX otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ChitogenX more accurately as focusing exclusively on ChitogenX's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details
Hype
Prediction
LowEstimatedHigh
0.000.017.94
Details
Naive
Forecast
LowNext ValueHigh
0.00006907.93
Details

ChitogenX Total Value Analysis

ChitogenX is currently anticipated to have takeover price of 12.49 M with market capitalization of 9.86 M, debt of 4.78 M, and cash on hands of 2.19 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the ChitogenX fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
12.49 M
9.86 M
4.78 M
2.19 M

ChitogenX Asset Utilization

One of the ways to look at asset utilization of ChitogenX is to check how much profit was generated for every dollar of assets it reports. ChitogenX shows a negative utilization of assets of -2.92 percent, losing $0.0292 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of ChitogenX shows how discouraging it operates for each dollar spent on its assets.

ChitogenX Ownership Allocation

ChitogenX holds a total of 51.04 Million outstanding shares. ChitogenX shows 17.44 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

ChitogenX Profitability Analysis

Net Loss for the year was (4.92 M) with profit before overhead, payroll, taxes, and interest of 0.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ChitogenX's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ChitogenX and how it compares across the competition.

About ChitogenX Valuation

The otc valuation mechanism determines ChitogenX's current worth on a weekly basis. Our valuation model uses a comparative analysis of ChitogenX. We calculate exposure to ChitogenX's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ChitogenX's related companies.
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada. Chitogenx is traded on OTC Exchange in the United States.

8 Steps to conduct ChitogenX's Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates ChitogenX's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ChitogenX's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain ChitogenX's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine ChitogenX's revenue streams: Identify ChitogenX's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research ChitogenX's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish ChitogenX's growth potential: Evaluate ChitogenX's management, business model, and growth potential.
  • Determine ChitogenX's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ChitogenX's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

ChitogenX Growth Indicators

Investing in growth stocks can be very risky. If the company such as ChitogenX does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding35 M
Retained Earnings-18.9 M

Complementary Tools for ChitogenX OTC Stock analysis

When running ChitogenX's price analysis, check to measure ChitogenX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChitogenX is operating at the current time. Most of ChitogenX's value examination focuses on studying past and present price action to predict the probability of ChitogenX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChitogenX's price. Additionally, you may evaluate how the addition of ChitogenX to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Technical Analysis
Check basic technical indicators and analysis based on most latest market data